DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

Clinical trial NCT03237325 · COMPLETED

Trial details

NCT number: NCT03237325
Sponsor: Soligenix
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Oral Mucositis

Start date: 2017-12-04
Primary completion: 2020-06-24
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.